Non-steroidal Anti-inflammatory Drugs (NSAIDs) and Risk of Acute Kidney Injury in Patients With Heart Failure
NCT02642081 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2016-01-07
Summary
The purpose of this study is to evaluate whether non-steroidal anti-inflammatory drugs (NSAIDs) were associated with acute kidney injury (AKI) in patients with heart failure. In addition, the investigators would like to assess the risk of admission for acute decompensated heart failure following exposure to NSAIDs within 30 days.
Conditions
Sponsors & Collaborators
-
National Taiwan University Hospital
lead OTHER
Principal Investigators
-
Chii-Ming Lee · National Taiwan University Hospital
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-01-31
- Primary Completion
- 2016-06-30
- Completion
- 2016-06-30
Countries
- Taiwan
Study Locations
More Related Trials
-
Perioperative Use of NAC to Prevent AKI in Patients With Pre-existing Moderate Renal Insufficiency Following Cardiac Surgery
NCT05555511 ·Status: UNKNOWN ·Phase: NA
-
Contrast-associated Acute Kidney Injury in Patients With Different Types of Coronary Artery Disease
NCT04163484 ·Status: COMPLETED
-
Prevention of Acute Kidney Injury in Patients With NSTEMI
NCT04912141 ·Status: TERMINATED ·Phase: PHASE2
-
Impact of Nicotinamide Riboside (NR) on Kidney Function in Patients Undergoing Cardiac Surgery
NCT06521307 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Prevention of Contrast Induced Nephropathy in Patients With Advanced Renal Dysfunction Undergoing Coronary Interventions
NCT02468401 ·Status: COMPLETED ·Phase: NA
-
The Use of Nesiritide in Thoracic Aneurysm Repair to Prevent Acute Renal Failure
NCT00110201 ·Status: UNKNOWN ·Phase: PHASE3
-
The Use of Inorganic Nitrate for the Prevention of Contrast-induced Nephropathy
NCT03627130 ·Status: COMPLETED ·Phase: PHASE2
-
N-Acetyl Cystein and Contrast Nephropathy
NCT01820195 ·Status: UNKNOWN ·Phase: PHASE3
-
Continuing or Discontinuing ACE/ARBs in Patients With Chronic Kidney Disease Undergoing Coronary Angiography
NCT05271448 ·Status: UNKNOWN ·Phase: NA
-
Effect of Continuing vs. Discontinuing ACE Inhibitors on Renal Function After Coronary Angiography
NCT07184918 ·Status: COMPLETED ·Phase: NA
-
Prophylactic Effect of Nifedipine on Further Decline in Renal Function in Patients Undergoing Open-Heart Surgery
NCT00244530 ·Status: COMPLETED ·Phase: PHASE4
-
Renoprotective Effect of Febuxostat on Contrast Induced Acute Kidney Injury in Chronic Kidney Disease Patients Stage 3
NCT05264584 ·Status: COMPLETED ·Phase: NA
-
N-Acetylcysteine in Heart Failure With Coexistent Chronic Renal Failure
NCT00532688 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Pharmacodynamics Aspects Of Porcine Heparin Sodium, Produced by Eurofarma, Compared Heparin Sodium, Produced by APP Pharmaceuticasls, in Patients With Chronic Renal Failure
NCT01034488 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Theophylline, N-acetylcysteine, and Theophylline Plus N-acetylcysteine in Preventing Contrast-induced Nephropathy
NCT02088502 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Heme Arginate in Cardiac Surgery Patients
NCT02142699 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients
NCT00247507 ·Status: UNKNOWN ·Phase: PHASE4
-
Myocardial Salvage and Contrast Dye Induced Nephropathy Reduction by N-Acetylcystein
NCT00463749 ·Status: COMPLETED ·Phase: PHASE3
-
Ameliorating Contrast Induced Nephropathy After Coronary Angiography
NCT06139952 ·Status: COMPLETED ·Phase: PHASE4
-
Prevention of Contrast-induced Nephropathy in Patients With Acute Myocardial Infarction
NCT01160627 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Intravenous Iron Administration in Hemodialysis Patients
NCT00298441 ·Status: COMPLETED ·Phase: PHASE4
-
Development of a Biomarker Panel for the Earlier Prediction of Acute Kidney Injury in Patients With Diabetes
NCT00948116 ·Status: RECRUITING
-
The Correlation Between Oxidative Stress and Indinated Contrast-Media Nephrotoxicity
NCT00632892 ·Status: COMPLETED
-
Pharmacokinetics of Apixaban in Nephrotic Syndrome
NCT02599532 ·Status: COMPLETED ·Phase: PHASE1
-
Study of the Effect of N-acetyl Cysteine on the Renal Graft Function Biomarkers (IL18, NGAL)
NCT01403506 ·Status: UNKNOWN ·Phase: PHASE3